The evolution and impact of the American College of Chest Physicians consensus statement on antithrombotic therapy
- PMID: 12685061
- DOI: 10.1016/s0272-5231(02)00079-5
The evolution and impact of the American College of Chest Physicians consensus statement on antithrombotic therapy
Abstract
The evolution of the American College of Chest Physicians consensus on antithrombotic therapy is reviewed, specifically with regard to the prevention and treatment of venous thromboembolism and the rules of evidence applied. A perspective on the impact of the recommendations is offered.
Similar articles
-
Antithrombotic therapy for venous thromboembolic disease.Chest. 2001 Jan;119(1 Suppl):176S-193S. doi: 10.1378/chest.119.1_suppl.176s. Chest. 2001. PMID: 11157648 Review. No abstract available.
-
[Low-molecular weight heparins in the prophylaxis and treatment of pulmonary thromboembolism].Rev Esp Cardiol. 2001 Sep;54(9):1121-2. doi: 10.1016/s0300-8932(01)76463-9. Rev Esp Cardiol. 2001. PMID: 11535193 Spanish. No abstract available.
-
[Treatment guidelines for deep venous thrombosis and pulmonary embolus].Duodecim. 2001;117(24):2603-10. Duodecim. 2001. PMID: 12183822 Review. Finnish. No abstract available.
-
Prevention of venous thromboembolism: recommendations based on the International Consensus and the American College of Chest Physicians Sixth Consensus Conference on Antithrombotic Therapy.Clin Appl Thromb Hemost. 2001 Jul;7(3):171-7. doi: 10.1177/107602960100700301. Clin Appl Thromb Hemost. 2001. PMID: 11441977 Review.
-
[Anticoagulation in patients with venous thromboembolism].Ther Umsch. 2003 Jan;60(1):43-7. doi: 10.1024/0040-5930.60.1.43. Ther Umsch. 2003. PMID: 12638478 German.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical